Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Ciurea

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Frontiers in Immunology|October 5, 2018
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid ArthritisValentina Cecchinato, Gianluca D'Agostino, Lorenzo Raeli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2010
18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitisKlaus Strobel, Dorothee R Fischer, Giorgio Tamborrini, et al.
Journal of Autoimmunity|July 14, 2017
The epigenetic architecture at gene promoters determines cell type-specific LPS toleranceKerstin Klein, Mojca Frank-Bertoncelj, Emmanuel Karouzakis, et al.
EJNMMI Research|July 14, 2012
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRIDorothee R Fischer, Christian W A Pfirrmann, Veronika Zubler, et al.
Clinical and Experimental Rheumatology|June 29, 2026
Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparisonMarlene Stirnimann-Agustoni, Julia-Tatjana Maul, Enriqueta Vallejo-Yagüe, et al.
Annals of the Rheumatic Diseases|February 11, 2015
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritisAdrian Ciurea, Almut Scherer, Ulrich Weber, et al.
Frontiers in Immunology|May 1, 2019
Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With LipopolysaccharidesMichel Neidhart, Agnieszka Pajak, Katerina Laskari, et al.
RMD Open|December 6, 2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registryAdrian Ciurea, Andrea Götschi, René Bräm, et al.
Arthritis Research & Therapy|March 14, 2023
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management RegistryVjara Popova, Seraphina Kissling, Raphael Micheroli, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|October 5, 2018
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid ArthritisValentina Cecchinato, Gianluca D'Agostino, Lorenzo Raeli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2010
18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitisKlaus Strobel, Dorothee R Fischer, Giorgio Tamborrini, et al.
Journal of Autoimmunity|July 14, 2017
The epigenetic architecture at gene promoters determines cell type-specific LPS toleranceKerstin Klein, Mojca Frank-Bertoncelj, Emmanuel Karouzakis, et al.
EJNMMI Research|July 14, 2012
High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRIDorothee R Fischer, Christian W A Pfirrmann, Veronika Zubler, et al.
Clinical and Experimental Rheumatology|June 29, 2026
Rising overweight and obesity in Swiss psoriatic arthritis patients, 2007-2022: a nationwide registry-population comparisonMarlene Stirnimann-Agustoni, Julia-Tatjana Maul, Enriqueta Vallejo-Yagüe, et al.
Annals of the Rheumatic Diseases|February 11, 2015
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritisAdrian Ciurea, Almut Scherer, Ulrich Weber, et al.
Frontiers in Immunology|May 1, 2019
Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With LipopolysaccharidesMichel Neidhart, Agnieszka Pajak, Katerina Laskari, et al.
RMD Open|December 6, 2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registryAdrian Ciurea, Andrea Götschi, René Bräm, et al.
Arthritis Research & Therapy|March 14, 2023
Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management RegistryVjara Popova, Seraphina Kissling, Raphael Micheroli, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Pageof 13